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A B S T R A C T
Background: Our previous preclinical study showed that the extract mixture (EM) of Andrographis paniculata
(Burm. f.) Wall. ex Nees (AP) and Syzygium polyanthum (Wight.) Walp (SP) leaves had antidiabetic effects and
were beneficial on alloxan-induced diabetic rats.
Purpose: The objectives of this study were to: 1) identify the phytochemical compounds present in aqueous
extract of AP and SP and 2) examine the benefits of the EM of AP and SP leaves in lowering blood glucose in the
presence of standard antidiabetic treatment using metformin in type 2 diabetic patients in Indonesian
Traditional Medicine Polyclinic of Dr. Soetomo General Hospital in Surabaya.
Methods: Phytochemical analysis of aqueous leaf extract of AP and SP was performed using standard chemical tests,
TLC, and GC–MS. Furthermore, a total of 54 subjects with T2DM participated in this study and were randomly
assigned to either the intervention group supplemented with the extract mixture of AP and SP at a dose 900 mg/day
for 8 weeks, or the control group which received placebo tablets in a randomized placebo-controlled double-blinded
parallel clinical trial. Both groups received metformin at dose 1000 mg/day. Body weight, blood pressure, fasting
blood glucose, postprandial glucose, haemoglobin A1c, triglycerides, total cholesterol, low density lipoprotein, high
density lipoprotein, and markers of liver and kidney damage were measured.
Results: The results of phytochemical analysis showed that the glycosides, terpenoids, alkaloids, flavonoids,
saponins, and tannins were found to be present in the extract mixture. GC–MS analyses of AP and SP showed the
presence of 19 and 12 peaks, respectively. Methyl ester of 9-octadecenoic and eicosanoic acid were determined
as the main constituents of both species. Moreover, the results of clinical study suggested that the extract mixture
improved the decrease of fasting blood glucose and postprandial glucose, significantly lowered body mass index
compared with the control group. The EM appeared beneficial for SGPT values and uric acid levels.
Conclusion: Overall, the results of this study suggested the potential beneficial effects of the extract mixture for use
as complementary medicine alongside conventional treatment of metformin. The extract mixture contained many
highly potent compounds for treating T2DM and preventing short- and long-term risk complications of diabetes.
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Introduction
Diabetes mellitus is becoming a serious complex chronic condition
that is a major health problem owing to the advancing age of popula-
tion, a substantially increased prevalence of obesity, and decreased
physical activity (Danaei et al., 2011). In Asia, the type 2 diabetes
mellitus (T2DM) has reached epidemic proportions characterized by
rapid rates of increase over short periods and onset at a relatively young
age and low body mass index (Chan et al., 2009; Ramachandran et al.,
2012). The important feature of diabetes is an elevated blood sugar
level (hyperglycemia) associated in approximately 90% of T2DM with
other cardiovascular factors, that constitute the metabolic syndrome.
For a significant number of patients, the treatment of T2DM must in-
clude pharmacological agents in order to reach satisfactory glycemic
control.
Since 1950, metformin, an oral hypoglycemic agent, has been re-
commended as first line pharmacotherapy to treat diabetic patients
(Holman, 2007; Wendy et al., 2011). Furthermore, metformin has also
been shown in studies to lower the risk of other complications of dia-
betes such as a substantial beneficial effect on cardiovascular, lipid
profile and arterial blood pressure of diabetic patients (Mourão-
Júnior et al., 2006). Although it is infrequent, lactic acidosis is the main
serious metabolic risk associated with metformin overdose
(Lheureux et al., 2009). Many diabetic patients in inadequate long-term
blood glucose control with metformin monotherapy require additional
treatment (Goldstein et al., 2003; Marre et al., 2002; Ponssen et al.,
2000). On another side, there has been an increasing interest in the use
of medicinal plants products for treating type 2 diabetic patients in the
recent years (Bahmani et al., 2014; Mirhoseini et al., 2013; Nasri et al.,
2015). Combinations of the common medications used to treat or re-
duce the symptoms of T2DM with medicinal plants may increase the
efficacy and safety of the treatments in synergistic manner.
According to traditional Indonesian medicine, Andrographis panicu-
lata (Burm. f.) Wall. ex Nees (AP) is described as one among the
prioritized medicinal plants and this herb is being used mainly for jamu
pahitan, whose use is a part and parcel of Indonesian culture recognized
internationally (Komalasari and Harimurti, 2015; Lanawati et al., 2012;
Limyati and Juniar, 1998). The antidiabetic effects of A. paniculata have
been investigated by number of researchers from in silico studies to
human evidence (Kooti et al., 2016; Niranjan et al., 2010;
Nizmawardini et al., 2013; Xu et al., 2007, 2010). It has also a wide
range of pharmacological effects (Akhtar et al., 2016; Jayakumar et al.,
2013; Rajasekaran et al., 2016), including hepatoprotective (Nasir
et al., 2013; Vetriselvan and Middha, 2016), antioxidant (Dandu and
Inamdar, 2009), and anti-inflammatory (Zou et al., 2016), which are
beneficial for people with T2DM, since it may help minimize compli-
cations of diabetes. On the other hand, Syzygium polyanthum (Wight.)
Walp (SP) or Indonesian bay leaves commonly used spices was assessed
for antidiabetic activity in Indonesia (Anggowati and Sukrasno, 2004;
Studiawan and Santosa, 2005; Wahyono and Susanti, 2008; Widyawati
et al., 2015) with the beneficial effect of antioxidants (Lelono et al.,
2009), and it has been reported to promote wound healing, which is
seriously blunted in diabetes (Bowling et al., 2015; Sumono and Wulan,
2008).
In our previous study, AP and SP were selected for examination of
their antidiabetic effects (Widharna et al., 2015). We found that the 6 :
1 (w/w) mixture of the two aqueous extracts showed antidiabetic ef-
fects with improvement of pancreatic islet cells in alloxan-induced
diabetic male rats. In this work, we examined the effects of supple-
mentation with metfomin alone and metformin combined with extract
mixture (EM) at a dose 900 mg/day on blood glucose, and other me-
tabolic markers. The present work deals with the phytochemical ana-
lysis, identification of volatile compounds of the extracts and whether
the extract mixture could complement the standard antidiabetic treat-
ment with metformin and render added protection to patients with




The leaves of A. paniculata and S. polyanthum were collected from
the area of Pandaan, East Java, Indonesia. The leaves were washed,
rinsed, blotted, sliced and grounded. The phytochemical constituents
were extracted in leaf/water ratio of 1 : 4 (g/ml) at 80 °C for 4 h. The
solvent was evaporated in vacuo (50 – 60 mmHg) and the aqueous
extracts were mixed with 10% maltodextrin. Subsequently, the drying
process was carried out using spray-drying technology in PT. Natura
Laboratoria Prima. The powder yield of aqueous extracts was dried to
approximately 10% of its initial weight (Widharna et al., 2015). The
extract mixture has been formulated into tablets having the best com-
bination of antidiabetic potencies (Hendriati et al., 2011). All tablet
formulations were prepared in the laboratory of the Faculty of Phar-
macy, Widya Mandala Catholic University Surabaya, Indonesia.
Phytochemical screening
Test for glycosides
Sample was mixed with 2ml of water, followed by 0.2 ml of 0.1M
HCl to hydrolyze the glycosides. A control was maintained in the same
manner, except that water was used instead of the acid. The mixture
was kept boiling for 5 min in water bath. Finally, equal volume of
Fehling A and Fehling B reagents were added while continuing to shake
the mixture in the bath for 10 min. A brick-red precipitate formed from
the hydrolysis of glycosides indicated the presence of glucosides.
Test for terpenoids (Salkwoski test)
Ten mg was dissolved in 2 ml of CHCl3 and evaporated to dryness.
Concentrated sulphuric acid (2 ml) was then added and heated for
about 2 min. Development of a greyish colour indicates the presence of
terpenoids.
Test for alkaloids (Dragendorff test)
About 10 mg of sample was warmed with 2% sulphuric acid for
2 min. It was filtered and few drops of Dragendorff's reagent was added
and observed for colour change. Positive test gives an orange red pre-
cipitate.
Ammonium test for flavonoids
A portion of sample was heated with 10 ml of ethyl acetate in water
bath for 3 min. The mixture was filtered and 4 ml of filtrate was shaken
with 1ml of dilute ammonia solution. A yellow coloration was taken as
a positive test for presence of flavonoid.
Test for saponin
Sample was mixed with 5ml of water in a test tube, warmed and
shaken vigorously. The formation of stable foam indicated the presence
of saponins.
Test for tannin
About 0.5 ml of the sample was boiled in 10 ml of water in a test
tube and then filtered. Few drops of 0.1% ferric chloride were added. A
brownish green or a blue-black coloration was taken as a positive test
for presence of tannin.
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TLC-analysis
Standard solutions containing 7000 ppm AP, SP and EM respec-
tively were prepared in methanol and aquadest (5 : 1.5, v/v). Ten µL of
the samples were applied on a precoated silica gel F254 aluminium
plate. The plate was developed in ethyl acetate : methanol (3 : 7, v/v)
and the developed plate was visualized and scanned under UV 254 and
366 nm by means of Camag TLC scanner 3 (densitometer).
Gas chromatography/mass spectrometry (GC/MS) analysis
The GC–MS instrument (Shimadzu GCMS-QP2010S, Japan) was
utilized in this analysis. The aqueous extract of AP and SP were ana-
lyzed on capillary column (Agilent J&W DB-1,
30m×0.25 µm × 0.25 µm). The injector temperature was set at
310 °C, column temperature program was set at 80 °C (0 min) with an
increasing rate of 10–300 °C (33 min). The carrier gas used was helium
gas with a constant flow of 0.5 ml/min. The ion source was electron
ionization (EI) operating at 70 eV. The temperature of ion source was
set as 250 °C and the interface temperature was 305 °C with its solvent
cut-off time of 3.0 min. The start time was set at 3.2 min and the end
time was set at 60 min. The compounds were identified by comparing
the retention indices with those reported in the literature and by
comparing their mass spectra with the Wiley GC/MS Library and NIST.
Only the peaks with similarity index of 80% or above were selected.
Clinical evaluation
The research protocol was approved by the Medical Ethics
Committee of Dr. Soetomo General Hospital in Surabaya. The study was
registered under number: 162/Panke.KKE/VII/2012. Sixty six patients
with T2DM who repeatedly visited the Indonesian Traditional Medicine
Polyclinic of Dr. Soetomo General Hospital in Surabaya were enrolled
in a randomized placebo controlled double-blinded single centre clin-
ical trial. The following inclusion criteria were used to recruit the
subjects with T2DM: (1) men or women diagnosed with diabetes at
age≥ 30 years, (2) taking no other medicines such as steroid or weight
loss drug that could influence blood glucose level (3) being not on any
other hypoglycemic treatment for minimum two weeks before the study
(4) willingness to follow the research protocol. Patients with type 1
diabetes, diabetes with complications, allergy to AP, SP, or metformin,
chronic or acute hepatic disease, cardiovascular disease for minimum of
12 months before the study were excluded from the present study.
At first screening visit, patients were evaluated for eligibility cri-
teria. After being informed about the details of the study orally and in
printed matter, those who agreed to participate signed a free and in-
formed consent form. Patients were randomized to the intervention
group and the control group by randomly drawing lots previously de-
fined by a non-participant of the study. On the next day all patients
came after overnight fasting and after physical examination, blood was
collected for biochemical examination including fasting blood glucose,
postprandial glucose, haemoglobin A1c, triglycerides, total cholesterol,
low density lipoprotein, high density lipoprotein, SGOT, SGPT, uric
acid, creatinine, and BUN served as baseline values.
All patients took a single dose of 500 mg twice a day of metformin
tablets. In the intervention group, the patients received 450 mg twice a
day of EM tablets (Nair and Jacob, 2016), while in the control group the
patients received a placebo tablet twice a day as well. Subsequently,
patients were asked to attend the Indonesian Traditional Medicine
Polyclinic of the Dr. Soetomo General Hospital in Surabaya in week 4
and week 8 after overnight fasting. The general physical and bio-
chemical examination was performed at the first and the third visits to
observe possible outcomes of extract mixture therapy in patients who
were receiving metformin as a standard medical treatment of diabetes
mellitus type 2. At the second visit, only the biochemical examination
was carried out, except HbA1c test. Both the clinical team and parti-
cipants were blinded from the time of randomization until analysis was
completed.
Statistical analysis
All data were expressed as mean ± SD and a p-value less than 0.05
was considered statistically significant (Table 3). For categorical vari-
ables, the two groups were compared with contingency table analyses
using chi-square statistics. A two-tailed τ-test was used to compare
groups for continuous variables,. The paired Student's τ-test was used to
compare the means of two variables for a single group. The sign test or
Wilcoxon signed-rank test was used as an alternative to the paired
Student's τ-test for dependent samples when the variables cannot be
assumed to be normally distributed.
Results
The aqueous extract of AP and SP, and extract mixture were sub-
jected to phytochemical screening for the presence of glycosides, ter-
penoids, alkaloids, flavonoids, saponins, and tannins. The results of
phytochemical analysis were given in Table 1. TLC photodocumenta-
tion of AP, SP and EM are shown in Fig. 1, while their Rf values of the
spots and TLC densitometric scan at UV 254 and 366 nm were shown in
Fig. 2. The GC–MS analysis of AP and SP showed the presence of 19 and
12 phytochemical compounds representing the total volatile fraction of
AP (95.54%) and SP (86.83%) respectively (Fig. 3). The relative con-
centrations of the volatile components identified are presented in
Table 2.
Sixty-six patients were fulfilled the selection criteria and agreed to
sign the letter of informed consent. Twelve of these patients were lost
during follow-up, whereas fifty-four patients were followed until the
end of the study. Table 3 shows the general characteristics of the in-
tervention group compared with the controls. At the baseline level,
there was no significant difference between the two groups regarding
age and gender. The mean of age of patients were 52.55 ± 10.04
(female 18, male 9) and 53.74 ± 9.25 (female 14, male 13) for the
control and intervention groups, respectively.
EM and placebo supplementation had no effect on systolic and
diastolic blood pressure, HbA1c, triglycerides, HDL-cholesterol, SGOT,
GGT, creatinine, and BUN in Table 4. For more detailed information,
see Supplementary Figs. S3 and S4. Total cholesterol and LDL choles-
terol were significantly reduced in both groups.
The decrease in fasting blood glucose levels (FPG) was significant
with extract mixture supplementation only for 4 weeks (visit 2), but
after 8 weeks (visit 3) the treatment of the patients with extract mixture
did not result any change in fasting blood glucose level compared to
before the treatment, while the control groups had no change in fasting
blood glucose level when compared to their baseline levels throughout
the study (Table 4).
The body mass index (BMI) values were unchanged in the control
group, while it decreased significantly in the intervention group
(Table 4). Changes in BMI showed a decreasing trend but were
Table 1
Photochemical screening for the EM of A. paniculata and S. polyanthum leaves.
No. Phytochemicals Ap Sp EM
1. Glycosides + + +
2. Terpenoids + + +
3. Alkaloids − + +
4. Flavonoids + + +
5. Saponins + − +
6. Tannins − + +
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statistically significant only in the intervention group. Before the
treatment, most patients in both groups were overweight
(25≤BMI< 30 kg/m2), which were changes in BMI in the control and
intervention group, respectively. Treatment of patients with the extract
mixture for 8 weeks improved significantly the BMI values to normal
weight.
Postprandrial glucose levels (PPG) showed a significant reduction
compared to baseline levels in the intervention group, while the sig-
nificant decrease of PPG in the control group could only be detected at
visit 2 or 4 treatment weeks (Table 4). When compared to the control
group, the decline in PPG was higher with extract mixture in subjects
supplemented with the extract mixture, even though no significant
difference was found between both groups. However, distribution of
PPG before and after treatment indicated that the distribution for the
intervention group shifted to the smaller value after treatment, while
the distribution for the intervention group widened compared to the
baseline values.
Liver function markers (SGOT and GGT) were unchanged with the
extract mixture treatment for 56 days in type 2 diabetic patients in both
groups (Table 4), while SGPT decreased significantly at the end of the
study in the intervention group. Patients in the control group showed a
significant increase in SGPT at visit 2 (4 treatment weeks), but it de-
creased to baseline values after treatments. On the contrary, the treat-
ment with the extract mixture produced a significant decrease in SGPT.
As markers of renal function uric acid, creatinine and BUN levels
were examined. When compared to the baseline levels, uric acid levels
for the intervention group remained stable, while it increased sig-
nificantly in the control group (Table 4). The other renal parameters
were unchanged with extract mixture treatment for 56 days.
Discussion
A. paniculata (AP) is one of the most well-studied medicinal plant,
with reports on its chemical constituents (Hossain et al., 2014; Sharma
et al., 2012; Srivastava et al., 2004). On the other hand, S. polyanthum
(SP), widely used as spices and traditional medicine in Indonesia and
Malaysia, has received more attention in recent years and its phyto-
chemical screening has been intensively investigated due to their po-
tentially wider safety margin and useful pharmacological effects
(Hassan et al., 2015; Kusuma et al., 2011; Rahim et al., 2018). The
Indonesian Traditional Medicine Polyclinic of Dr. Soetomo General
Hospital in Surabaya used extract mixture of AP-SP with ratio of 1:1 for
T2DM treatment. The dose suggested was 1 g three times a day (3 g a
day). In traditional use, herbal medicine comes mostly in form of herbal
decoctions, which are the simplest forms of herbal preparation. Several
studies have compared various pharmacological effects of aqueous and
ethanolic extracts of herbal medicines, but there was no general con-
clusion which kind of extract had better activities (Hosseinzadeh et al.,
2014; Hosseinzadeh et al., 2013; Ju and Kim, 2008; Singh, 2010).
However, our previous work showed that there was no significant dif-
ference of hypoglycemic activity between aqueous and ethanolic ex-
tracts of Andrographolide paniculata on glucose tolerance test in rats
(Hendriati et al., 2010). Moreover, we reported that the extract mixture
of AP-SP with ratio of 6 : 1 was beneficial for pancreatic beta-cells
(Widharna et al., 2015). The development of parameters for standar-
dization in herbal medicine is a challenging task.
In this study, a phytochemical screening was performed for each
extract and tablets of the extract mixture (EM). The results obtained for
phytochemical analysis of AP, SP and EM indicate the presence of
glycosides, terpenoids, flavonoids, and saponins in AP, while glyco-
sides, terpenoids, alkaloids, flavonoids, and tannins were present in SP
as detailed out in the Table 1. Various major groups of phytochemicals
were detected to be present in EM and could be beneficial for diabetic
patients (Rahimi-Madiseh et al., 2014). Moreover, in the TLC analysis,
we reported that the best separation was achieved with mixture of ethyl
acetate : methanol (3 : 7, v/v) as a mobile phase. In Fig. 1, the photo
documentation of the plates showed several bands under UV 254 and
366 nm. There were 2 spots under 254 nm and 3 spots under 366 nm
for AP and EM, while no spot was observed for SP. However, densito-
metric scan of AP under 254, and 366 nm UV, revealed 6 and 5 peaks,
respectively, of which Rf 0.70 (22.55%) was recognized as major one
for 254 nm, and Rf 0.69 (30.18%) as major one for 366 nm (Fig. 2: A1
and B1). On the other side, densitometric scan of SP under 254 and 366
nm showed the presence of 5 and 4 peaks, respectively, of which Rf
0.80 (42.93%) was major one for 254 nm and Rf 0.76 was for 366 nm
in Fig. 2 part A2 and B2. EM resolved into peaks at similar wavelengths
to the ones of AP with a different area composition ratio (Fig. 2: A3 and
B3). These changes may be attributed to AP:SP ratio of 6 : 1. The TLC
analysis had been performed carefully with different developers (data
not shown) and one of those gave the best separation we reported in
this study. It was noted that there was one peak near the base band with
the lowest Rf value indicated the high-polarity compounds. Further
works, such as two-dimensional TLC analysis or LC-MS/MS, are clearly
needed to better standardize the extracts.
Previous studies using GC–MS determined the chemical profile of
chloroform extracts of the aerial part of AP (Roy et al., 2010), ethanol
whole crude extract (Kumar and Gani, 2017), acetone leaf extract
(Thangavel et al., 2015), ethanol leaf extract (Udobre et al., 2016;
Vasantha et al., 2013), and methanol leaf extract (Krishnamoorthy and
Kalaiselvan, 2016; Panda and Bandyopadhyay, 2013; Shalini and
Narayanan, 2015). Besides, the GC–MS analysis of n-hexane, ethyl
acetate, and methanol leaf extract of SP has been has been reported
(Rahim et al., 2018). However, the differences between the previous
results and our present finding could be due to the origin of the plants
and the different types of extraction. In the present study, the GC-Ms
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Fig. 1. TLC profile of AP (track 1), SP (track 2), and EM (track 3) at UV 254 nm
(A) and 366 nm (B) on silica 60 F254 with solvent system ethyl acetate : me-
thanol (30 : 70, v/v).
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than the aqueous extract of SP. The aqueous AP extract had nineteen
peaks whereas aqueous SP extract had twelve major peaks. The
common compounds in each extract were: peaks 2, 5, 8, 15, 17, 20, 21,
and 22 with RT 16.22, 18.36, 18.76, 20.86, 21.12, 22.81, 22.90, and
23.16 for AP and peaks 3, 8, 12, 14, 15, 17, 18, and 19 with RT 16.22,
18.35, 18.77, 20.87, 21.12, 22.82, 22.90, and 23.16 for SP, which were
86% and 82% of total volatile fraction for AP and SP respectively. Fatty
acids and esters (AP: 74. 57%, SP: 62.82%) were found to be the highest
constituents in the crude extract followed by terpenoids (AP: 11.16%,
SP: 12.30%) and hydrocarbons (AP: 6.19%, SP: 9.87%). The most
abundant compound were the esters 9-octadecenoic acid, methyl ester
(AP: 26.65%, SP: 27.07%) and eicosanoic acid, methyl ester (AP:
24.47%, SP: 17.23%).
The reliability of the usage of medicinal plants is correlated with the
phytochemical compounds Some compounds were shown to possess
important biological activities. For instance, 9-octadecenoic acid (Z)-,
methyl ester, the highest content of the extracts has anti-inflammatory,
antiandrogenic, and anemiagenic properties (Surender et al., 2008).
The other compound, eicosanoic acid, methyl ester, the second highest
content of both extracts showed α-glucosidase inhibitor activity
(Artanti et al., 2012). Caryophyllene oxide, a bicyclic sesquiterpene,
showed strong anti-cancer effects against MG-63 human osteosarcoma
cells through suppression of cancer cell migration tendency and in-
duction of apoptosis (Pan et al., 2016). Furthermore, 9,12-octadeca-
dienoic acid (Z,Z)-, methyl ester or methyl linoleate used as a flavouring
ingredient possesses antifungal and antioxidant activities. All the major
compounds identified in the present analysis were obviously different
with the major ones in the previous studies mentioned earlier. These
findings suggested the beneficial effects of the extracts and that the
antidiabetic activities of the aqueous leaf extracts of AP and SP might be
related to the presence of eicosanoic acid, methyl ester. Moreover, in
order to analyze andrographolide in AP, and apigenin and quercetin in
SP, an HPLC method was employed. This approach was not successful
in separating the compounds in the extracts due to insufficient column
selectivity and efficiency. The HPLC results can be find in Supplemen-
tary Materials (Figs. S1 and S2).
Potencies of AP and SP leaves against different ailments have been
evaluated by numerous studies (Kusuma et al., 2011; Rajasekaran et al.,
2016; Sundari, 2010; Widyawati et al., 2015). However, clinical trials
investigating their antidiabetic effects are still limited.
Agarwal et al. (2005) reported that treatment with dry powder of aerial
part of AP starting with 600 mg, gradually increasing to a maximum of
1.8 g/day for 12 weeks, resulted a significant fall in HbA1c and fasting
serum insulin and did not induce significant adverse events on 20 pa-
tients with type 2 diabetes mellitus. Another study has been done by
Nizmawardini et al. using metformin and dry extract of A. paniculata
leaves with dosage 1.54 g/day for 14 days in 34 diabetic patients
showed some effects on PPG (Nizmawardini et al., 2013). However, the
study was quite short in duration and it lacked information about the
impact of the extract on organs involved in detoxification. The only one
clinical trial that involved applying both extracts AP and SP (1:1) 2.1
g/day with metformin 500 mg/day on 30 diabetic patients was
Fig. 2. TLC Densitometric scan of AP (1), SP (2), and EM (3) at UV 254 nm (A) and 366 nm (B).
E.C. Widjajakusuma et al. Phytomedicine 55 (2019) 137–147
141
conducted by Suharmiati and Roosihermiatie (2012). The results
showed a significant reduction in FPG levels compared to FPG levels
before treatment and no adverse effects of high dose extracts after 4
weeks of treatments on 15 diabetic patients intervention group, while
the FPG levels in the control group were changed not significantly.
Nevertheless, there was no scientific evidence available indicating that
an extract ratio of 1 : 1 was the most favourable ratio for diabetic pa-
tient. Based on our previous study, we found that the extract ratio of 6 :
1 (AP:SP) potently restored pancreatic islet cells of Wistar rats com-
pared to the other ratios (Widharna et al., 2015). Therefore, the study
reported here was designed to evaluate the safety and efficacy of the
extract ratio of 6 : 1 (AP:SP) supplementation for diabetic patients with
a larger sample size and a longer time of therapy compared to previous
studies. This had the advantage of better results in the safety and effi-
cacy analysis of the extract mixture in diabetic patients (Fig. 4).
Metformin is one of two classes oral antidiabetic agents that has not
been related with weight gain (Golay, 2008). It may help people with
diabetes to lose weight by reducing food intake (Lee and Morley, 1998;
Paolisso et al., 1998). It is clearly important to avoid unnecessary
weight gain for diabetic patients, particularly patients who are already
overweight or obese. In the present work, the intervention group re-
vealed a significant improvement of mean body mass index compared
to the control group (Table 3). This observation is interesting since it
means that we may combine other antidiabetic agents, especially, that
can increase body weight such as insulin secretagogues or insulin itself,
with the EM for treating T2DM (Fig. 5).
Data concerning interaction of AP with some conventional drugs
like naproxen with synergetic effect (Balap et al., 2017), theophylline
and midazolam (Jutiviboonsuk, 2015) have been reported. Although
interaction data of AP with antidiabetic drug have not been reported
(Gupta et al., 2017), AP has been shown to inhibit CYP2C19 activity
(Jutiviboonsuk, 2015; Pan et al., 2011). Therefore, AP has the potential
to interact with some antidiabetic drug such as glibenclamide and gli-
mepiride, but not with metformin. On the other hand, there was no
information about drug interaction of SP but based on its daily used in
Indonesian cuisine, we can expect that it is most probably safe taken
with metformin. A suggested dose of the Indonesian Traditional Med-
icine Polyclinic, Dr. Soetomo General Hospital in Surabaya was 3 g per
day as mentioned earlier.
One of the central issues in the treatment of patients with type 2
diabetes is achieving glycemic control to prevent the microvascular and
macrovascular complications of diabetes. Control of plasma glucose in
diabetic patients can be evaluated by measuring glycated haemoglobin
(HbA1c), fasting plasma glucose (FPG), and postprandial glucose (PPG).
An overall picture of average blood glucose levels over the past two to
three months can be provided by measuring glycated haemoglobin
Fig. 3. GC–MS Chromatogram of A. paniculata (A) and S. polyanthum (B).
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(HbA1c). If HbA1c test is not available, postprandial and fasting plasma
glucose can be estimated to assess glycemic control. Based on our re-
sults (Table 3), there were trends towards a decrease, but no significant
changes were observed in FPG and HbA1c with the EM supplementa-
tion, while a significant decrease in PPG was observed in the inter-
vention group. It should be noted that even after treatment for 56 days,
the FPG had not fallen to normal values; this is probably because the
dose is not high enough. However, treatment with metformin and the
extract mixture produced a significant decrease in postprandial glucose
levels within eight weeks. The relationship between PPG and HbA1c
has been studied extensively and some found that PPG strongly corre-
lated with HbA1c or contributes significantly to overall glycemic con-
trol (Ketema and Kibret, 2015). The results suggested that the EM im-
proves glycemic in the type 2 diabetic patients.
A significant increase in SGPT at visit 2 in the control group was in
accordance with the findings of hepatoxicity of metformin (Bernal-
Lopez et al., 2012; Vagula and Devi, 2008). However, metformin-in-
duced hepatotoxicity is very rare and only few cases have been reported
in the literature (Aksay et al., 2007; Babich et al., 1998; Deutsch et al.,
2004; Zheng, 2016). The results of the current study showed that the
SGPT levels were unchanged in the intervention group, while there was
a significant increase at visit 2 in the control group indicated that ex-
tract mixture may mitigate the hepatotoxic effect or even could fortify
liver against this effect. Our results are in good agreement with pre-
vious investigations for indicating the hepatoprotective activity of
aqueous and methanolic extracts of A. paniculata (Sutha et al., 2010;
Trivedi and Rawal, 2001).
Another serious but rare side effect of metformin is lactic acidosis
because of its inference with mitochondrial oxidative processes. While
metformin-induced hepatotoxicity has been rarely reported, metfomin-
associated metabolic acidosis is a widely recognized side effect of this
drug (DeFronzo et al., 2015). Metformin is contraindicated in many
type 2 diabetic patients with impaired renal function because of con-
sideration of lactic acidosis (Inzucchi et al., 2014). Impaired renal
function can result in increase of uric acid, creatinine, and BUN levels.
Furthermore, metabolite syndrome such as diabetes is one of several
factors associated as cause and consequences of high uric acid con-
centration. Our results showed that the uric acid level in the inter-
vention group compared to baseline values had no change, while it
increased significantly in the control group. This may indicate the
ability of the extract mixture to provide some degree of protection to
the kidney. The renoprotective of the extract mixture treated type 2
diabetic patients is in accordance with that observed by
Singh et al. (2009).
Conclusion
In the present study, the extract mixture showed the presence of
bioactive compound such as glycosides, terpenoids, alkaloids, flavo-
noids, saponins, and tannins. Our GC and GC–MS study of the aqueous
leaf extracts of A. paniculata and S. polyanthum revealed the presence of
major compounds such as 9-octadecenoic acid (Z)-, methyl ester, ei-
cosanoic acid, methyl ester, and caryophyllene oxide with therapeutic
importance. The main constituents were fatty acids and ester, terpe-
noids and hydrocarbons that justify the traditional usage of the plants.
This study also leads to the further research in the way of isolation and
identification of the active compound from the A. paniculata and S.
polyanthum using extraction, chromatographic and spectroscopic tech-
niques.
Our data showed that the combination of the extract mixture at a
dose of 900 mg/day with the standard treatment of metformin at a dose
of 1000 mg/day had an effect in lowering postprandrial glucose levels,
along with major improvements in other metabolic parameters in
Table 2
Phytochemical compounds identified in leaf aqueous extracts of A. paniculata and S. polyanthum by GC–MS.
Compounds Formula Mass Area% RT/line
AP SP AP SP
Fatty acids and esters 74.57 62.82
Decanoic acid, methyl ester C11H22O2 186 0.93 18.85/9
Nonanoic acid, methyl ester C10H20O2 172 1.48 18.86/13
Eicosanoic acid, methyl ester C21H42O2 326 24.47 17.23 21.13/17 21.12/15
Hexadecanoic acid, ethyl ester C18H36O2 284 1.96 21.82/18
9,12-Octadecadienoic acid (Z,Z)-, methyl ester C19H34O2 294 4.99 7.96 22.81/20 22.82/17
9-Octadecenoic acid, methyl ester C19H36O2 296 26.65 27.07 22.90/21 22.90/18
Tricosanoic acid C24H48O2 368 14.58 9.08 23.16/22 23.16/19
Ethyl octadec-9-enoate C20H38O2 310 0.99 23.53/23
Terpenoids 11.16 12.30
Guaiol C15H26O 222 1.68 16.07/1
(-)-Caryophyllene oxide C15H24O 220 7.86 12.3 18.36/5 18.35/8
Dihydrocarvyl acetate C12H20O2 196 1.02 19.15/11
α-Limonene diepoxide C10H16O2 168 0.6 19.57/12
Hydrocarbons 6.19 9.87
Cyclopropane, 1-(2-methylene-3-butenyl)−1-(1-methylenepropyl)- C12H18 162 1 15.4/1
1-Tridecene C13H26 182 1.18 16.083/2
Tetradecane C14H30 198 3.34 4.94 16.22/2 16.217/3
1-Decene C10H20 140 1.44 18.475/9
1-Hexadecene C16H32 224 0.63 18.47/6
Hexadecane C16H34 226 1.9 1.31 18.76/8 18.767/12
1-Tetradecene C14H28 196 0.32 19.81/13
Eicosane C20H42 282 0.41 21.01/16
Ketones 2.17 1.84
2-Pentadecanone C15H30O 226 2.17 1.84 20.86/15 20.875/14
Others 1.04 0
Myristyl chloride C14H29Cl 232 0.57 19.92/14
Silicate anion tetramer C24H72O12Si12 888 0.47 28.79/26
Table 3
Demographic characteristics of patients in control and intervention group.
Control group Intervention group P value
Age (year) 52.55 ± 10.04 53.74 ± 9.25 0.986
Sex (female/male) 18/9 14/13 0.268
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humans with type 2 diabetes mellitus. Moreover, the extract mixture
may assist in ameliorating weight gain associated with other anti-
diabetic agents. The present study also clearly indicated the hepato-
protective and renoprotective effects of A. paniculata. The combination
of the extract mixture with metformin for the management of type 2
diabetes is highly encouraged with a reduction in the dose of metformin
and an increase in the dose of the extract mixture (to guarantee efficacy
and safety).
To conclude, it was understood from the present study that the
extract of AP and SP contained many phytochemicals as revealed by
phytochemical studies, TLC and GC–MS analysis. The results of our
current study of 54 diabetic patients revealed the potential of the ex-
tract mixture of A. paniculata and S. polyanthum leaves in the treatment
of type 2 diabetes mellitus in patients receiving metformin.
Combination of metformin with the extract mixture is a promising
therapeutic option for not only improving glycemic control but also
being beneficial for liver and kidney which can be harmed by met-
formin on rare occasion.
Limitation
The TLC and GC–MS analysis were the first step towards under-
standing the nature of active compounds. Certainly, further studies are
warranted to standardize the extract mixture, especially non-volatile
compounds.
Despite providing a benefit, the current clinical study lacks sample
size calculation and as a result has a low sample size, since this is the
first report of the clinical use of aqueous extract mixture of AP and SP.
We may commit type 2 error due to the absence of prior sample size
calculation and the small sample size may lead to high chance of in-
sufficient power to detect real effects is particularly troubling, where
we fail to detect a difference where actually there is a difference. We
should be cautious with the fact that there is no statistical significance
doesn't mean the treatment failed. The study had a relatively short 8-
week duration and a low dose of the extract mixture (900 mg/day). A
larger patient sample size, a higher dose and a longer duration, there-
fore, will be needed to validate our findings.
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Visit 3 26.37 ± 0.91 25.93 ± 0.69
Systolic blood pressure (mmHg)
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Fig. 4. CONSORT follow chart of the clinical study.
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